FFNT.CN
4Front Ventures Corp
Price:  
0.03 
CAD
Volume:  
140,758.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FFNT.CN EV/EBITDA

-2598.6%
Upside

As of 2024-12-13, the EV/EBITDA ratio of 4Front Ventures Corp (FFNT.CN) is -4.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FFNT.CN's latest enterprise value is 119.37 mil CAD. FFNT.CN's TTM EBITDA according to its financial statements is -27.29 mil CAD. Dividing these 2 quantities gives us the above FFNT.CN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 14.4x - 33.3x 14.4x
Forward P/E multiples 15.7x - 34.4x 16.3x
Fair Price (0.64) - (1.26) (0.62)
Upside -2647.9% - -5125.5% -2598.6%
0.03 CAD
Stock Price
(0.62) CAD
Fair Price

FFNT.CN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-12 -3.38
2024-12-11 -3.38
2024-12-10 -3.59
2024-12-09 -3.59
2024-12-06 -3.79
2024-12-05 -3.59
2024-12-04 -3.99
2024-12-03 -3.79
2024-12-02 -3.99
2024-11-29 -3.99
2024-11-28 -4.39
2024-11-27 -3.99
2024-11-26 -4.39
2024-11-25 -3.99
2024-11-22 -3.99
2024-11-21 -4.19
2024-11-20 -4.19
2024-11-19 -4.19
2024-11-18 -4.39
2024-11-15 -4.19
2024-11-14 -4.19
2024-11-13 -3.99
2024-11-12 -4.19
2024-11-08 -4.39
2024-11-07 -4.39
2024-11-06 -4.79
2024-11-05 -4.99
2024-11-04 -4.99
2024-11-01 -4.79
2024-10-31 -4.59
2024-10-30 -4.59
2024-10-29 -4.79
2024-10-28 -4.99
2024-10-25 -5.19
2024-10-23 -5.59
2024-10-22 -5.59
2024-10-21 -5.19
2024-10-18 -5.19
2024-10-17 -4.99
2024-10-15 -5.19
2024-10-11 -5.19
2024-10-10 -5.19
2024-10-08 -5.19
2024-10-04 -5.39
2024-10-03 -5.19
2024-10-02 -5.19
2024-10-01 -5.19
2024-09-30 -4.99
2024-09-27 -4.99
2024-09-26 -4.99